Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases

Tingting Yue, Katie Partyka, Kevin A. Maupin, Mary Hurley, Philip Andrews, Karen Kaul, A. James Moser, Herbert Zeh, Randall E. Brand, Brian B. Haab

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The current best serum marker for pancreatic cancer, CA 19-9, detects a carbohydrate antigen on multiple protein carriers. Better knowledge of the protein carriers of the CA 19-9 antigen in various disease states may lead to improved diagnostic tests. To identify proteins that carry the CA 19-9 antigen, we immunoprecipitated the CA 19-9 antigen from pooled sera and identified the associated proteins using MS. Among the high-confidence identifications, we confirmed the presence of the CA 19-9 antigen on Apolipoprotein B-100 by antibody arrays and Western blot and on kininogen, ARVCF, and Apolipoprotein E by antibody arrays. We characterized the frequency and levels of the CA 19-9 antigen on the four proteins across various patient groups (pancreatic cancer, pancreatitis, and healthy controls) using antibody arrays. Nearly, 10-25% of the subjects showed elevations of the antigen on each protein, but the elevations were not associated with disease state or total CA 19-9 levels. These results contribute to our knowledge of the carrier proteins of an important functional glycan and the rate at which the glycan is displayed. This work also demonstrates a strategy for using the complementary methods of MS and antibody microarrays to identify protein carriers of glycans and assess the diagnostic value of measuring glycans on individual proteins.

Original languageEnglish (US)
Pages (from-to)3665-3674
Number of pages10
JournalProteomics
Volume11
Issue number18
DOIs
StatePublished - Sep 1 2011
Externally publishedYes

Fingerprint

CA-19-9 Antigen
Pancreatic Diseases
Blood Proteins
Polysaccharides
Carrier Proteins
Antibodies
Proteins
Pancreatic Neoplasms
Kininogens
Apolipoprotein B-100
Antigens
Apolipoproteins E
Microarrays
Routine Diagnostic Tests
Pancreatitis
Biomarkers
Western Blotting
Carbohydrates
Serum

Keywords

  • Antibody arrays
  • CA 19-9
  • Glycoproteomics
  • Glycosylation
  • Pancreatic cancer

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Yue, T., Partyka, K., Maupin, K. A., Hurley, M., Andrews, P., Kaul, K., ... Haab, B. B. (2011). Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases. Proteomics, 11(18), 3665-3674. https://doi.org/10.1002/pmic.201000827

Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases. / Yue, Tingting; Partyka, Katie; Maupin, Kevin A.; Hurley, Mary; Andrews, Philip; Kaul, Karen; Moser, A. James; Zeh, Herbert; Brand, Randall E.; Haab, Brian B.

In: Proteomics, Vol. 11, No. 18, 01.09.2011, p. 3665-3674.

Research output: Contribution to journalArticle

Yue, T, Partyka, K, Maupin, KA, Hurley, M, Andrews, P, Kaul, K, Moser, AJ, Zeh, H, Brand, RE & Haab, BB 2011, 'Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases', Proteomics, vol. 11, no. 18, pp. 3665-3674. https://doi.org/10.1002/pmic.201000827
Yue, Tingting ; Partyka, Katie ; Maupin, Kevin A. ; Hurley, Mary ; Andrews, Philip ; Kaul, Karen ; Moser, A. James ; Zeh, Herbert ; Brand, Randall E. ; Haab, Brian B. / Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases. In: Proteomics. 2011 ; Vol. 11, No. 18. pp. 3665-3674.
@article{c1938982cd034314a03bae79fda0b6e3,
title = "Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases",
abstract = "The current best serum marker for pancreatic cancer, CA 19-9, detects a carbohydrate antigen on multiple protein carriers. Better knowledge of the protein carriers of the CA 19-9 antigen in various disease states may lead to improved diagnostic tests. To identify proteins that carry the CA 19-9 antigen, we immunoprecipitated the CA 19-9 antigen from pooled sera and identified the associated proteins using MS. Among the high-confidence identifications, we confirmed the presence of the CA 19-9 antigen on Apolipoprotein B-100 by antibody arrays and Western blot and on kininogen, ARVCF, and Apolipoprotein E by antibody arrays. We characterized the frequency and levels of the CA 19-9 antigen on the four proteins across various patient groups (pancreatic cancer, pancreatitis, and healthy controls) using antibody arrays. Nearly, 10-25{\%} of the subjects showed elevations of the antigen on each protein, but the elevations were not associated with disease state or total CA 19-9 levels. These results contribute to our knowledge of the carrier proteins of an important functional glycan and the rate at which the glycan is displayed. This work also demonstrates a strategy for using the complementary methods of MS and antibody microarrays to identify protein carriers of glycans and assess the diagnostic value of measuring glycans on individual proteins.",
keywords = "Antibody arrays, CA 19-9, Glycoproteomics, Glycosylation, Pancreatic cancer",
author = "Tingting Yue and Katie Partyka and Maupin, {Kevin A.} and Mary Hurley and Philip Andrews and Karen Kaul and Moser, {A. James} and Herbert Zeh and Brand, {Randall E.} and Haab, {Brian B.}",
year = "2011",
month = "9",
day = "1",
doi = "10.1002/pmic.201000827",
language = "English (US)",
volume = "11",
pages = "3665--3674",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "18",

}

TY - JOUR

T1 - Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases

AU - Yue, Tingting

AU - Partyka, Katie

AU - Maupin, Kevin A.

AU - Hurley, Mary

AU - Andrews, Philip

AU - Kaul, Karen

AU - Moser, A. James

AU - Zeh, Herbert

AU - Brand, Randall E.

AU - Haab, Brian B.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - The current best serum marker for pancreatic cancer, CA 19-9, detects a carbohydrate antigen on multiple protein carriers. Better knowledge of the protein carriers of the CA 19-9 antigen in various disease states may lead to improved diagnostic tests. To identify proteins that carry the CA 19-9 antigen, we immunoprecipitated the CA 19-9 antigen from pooled sera and identified the associated proteins using MS. Among the high-confidence identifications, we confirmed the presence of the CA 19-9 antigen on Apolipoprotein B-100 by antibody arrays and Western blot and on kininogen, ARVCF, and Apolipoprotein E by antibody arrays. We characterized the frequency and levels of the CA 19-9 antigen on the four proteins across various patient groups (pancreatic cancer, pancreatitis, and healthy controls) using antibody arrays. Nearly, 10-25% of the subjects showed elevations of the antigen on each protein, but the elevations were not associated with disease state or total CA 19-9 levels. These results contribute to our knowledge of the carrier proteins of an important functional glycan and the rate at which the glycan is displayed. This work also demonstrates a strategy for using the complementary methods of MS and antibody microarrays to identify protein carriers of glycans and assess the diagnostic value of measuring glycans on individual proteins.

AB - The current best serum marker for pancreatic cancer, CA 19-9, detects a carbohydrate antigen on multiple protein carriers. Better knowledge of the protein carriers of the CA 19-9 antigen in various disease states may lead to improved diagnostic tests. To identify proteins that carry the CA 19-9 antigen, we immunoprecipitated the CA 19-9 antigen from pooled sera and identified the associated proteins using MS. Among the high-confidence identifications, we confirmed the presence of the CA 19-9 antigen on Apolipoprotein B-100 by antibody arrays and Western blot and on kininogen, ARVCF, and Apolipoprotein E by antibody arrays. We characterized the frequency and levels of the CA 19-9 antigen on the four proteins across various patient groups (pancreatic cancer, pancreatitis, and healthy controls) using antibody arrays. Nearly, 10-25% of the subjects showed elevations of the antigen on each protein, but the elevations were not associated with disease state or total CA 19-9 levels. These results contribute to our knowledge of the carrier proteins of an important functional glycan and the rate at which the glycan is displayed. This work also demonstrates a strategy for using the complementary methods of MS and antibody microarrays to identify protein carriers of glycans and assess the diagnostic value of measuring glycans on individual proteins.

KW - Antibody arrays

KW - CA 19-9

KW - Glycoproteomics

KW - Glycosylation

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=80052468511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052468511&partnerID=8YFLogxK

U2 - 10.1002/pmic.201000827

DO - 10.1002/pmic.201000827

M3 - Article

C2 - 21751362

AN - SCOPUS:80052468511

VL - 11

SP - 3665

EP - 3674

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 18

ER -